FLEX-NK Trademark

Trademark Overview

On Thursday, September 30, 2021, a trademark application was filed for FLEX-NK with the United States Patent and Trademark Office. The USPTO has given the FLEX-NK trademark a serial number of 97053648. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, July 10, 2024. This trademark is owned by Cytovia Therapeutics, Inc.. The FLEX-NK trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing technological information in the field of antibodies, natural killer cells, and pharmaceutical preparations for the treatment of cancer and tumors
flex-nk

General Information

Serial Number97053648
Word MarkFLEX-NK
Filing DateThursday, September 30, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, July 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 17, 2022

Trademark Statements

Goods and ServicesProviding technological information in the field of antibodies, natural killer cells, and pharmaceutical preparations for the treatment of cancer and tumors

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 28, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCytovia Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAventura, FL 33180
Party NameCytovia Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAventura, FL 33180

Trademark Events

Event DateEvent Description
Monday, October 4, 2021NEW APPLICATION ENTERED
Thursday, October 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 11, 2022ASSIGNED TO EXAMINER
Tuesday, April 12, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 27, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 17, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 17, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 12, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 11, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 11, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 11, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 12, 2023SOU TEAS EXTENSION RECEIVED
Thursday, January 12, 2023SOU EXTENSION 1 FILED
Thursday, January 12, 2023SOU EXTENSION 1 GRANTED
Saturday, January 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 11, 2023SOU EXTENSION 2 FILED
Tuesday, July 11, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, July 11, 2023SOU EXTENSION 2 GRANTED
Thursday, July 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 11, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 10, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 10, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 10, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 11, 2024SOU EXTENSION 3 FILED
Thursday, January 11, 2024SOU EXTENSION 3 GRANTED
Wednesday, July 10, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 10, 2024SOU EXTENSION 4 FILED
Wednesday, July 10, 2024SOU EXTENSION 4 GRANTED
Saturday, January 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

flex preparations pharmaceutical treatment cancer tumors cells killer information technological field